Grace Therapeutics, Stock Price History
| GRCE Stock | 3.23 0.05 1.52% |
Below is the normalized historical share price chart for Grace Therapeutics, extending back to February 07, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Grace Therapeutics, stands at 3.23, as last reported on the 22nd of November, with the highest price reaching 3.35 and the lowest price hitting 3.13 during the day.
If you're considering investing in Grace Stock, it is important to understand the factors that can impact its price. Grace Therapeutics, appears to be very risky, given 3 months investment horizon. Grace Therapeutics, holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of standard deviation over the last 3 months. By evaluating Grace Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please utilize Grace Therapeutics,'s risk adjusted performance of 0.0929, and Market Risk Adjusted Performance of (1.74) to validate if our risk estimates are consistent with your expectations.
At present, Grace Therapeutics,'s Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 13.4 M, whereas Total Stockholder Equity is forecasted to decline to about 58.7 M. . Grace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2024 |
Grace |
Sharpe Ratio = 0.1257
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GRCE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.68 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Grace Therapeutics, is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Grace Therapeutics, by adding it to a well-diversified portfolio.
Grace Therapeutics, Stock Price History Chart
There are several ways to analyze Grace Stock price data. The simplest method is using a basic Grace candlestick price chart, which shows Grace Therapeutics, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 23, 2024 | 3.6 |
| Lowest Price | September 12, 2024 | 2.13 |
Grace Therapeutics, November 22, 2024 Stock Price Synopsis
Various analyses of Grace Therapeutics,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Grace Stock. It can be used to describe the percentage change in the price of Grace Therapeutics, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Grace Stock.| Grace Therapeutics, Price Action Indicator | (0.03) | |
| Grace Therapeutics, Price Daily Balance Of Power | (0.23) | |
| Grace Therapeutics, Price Rate Of Daily Change | 0.98 |
Grace Therapeutics, November 22, 2024 Stock Price Analysis
Grace Stock Price History Data
The price series of Grace Therapeutics, for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 1.47 with a coefficient of variation of 12.29. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.94. The median price for the last 90 days is 3.05.| Open | High | Low | Close | Volume | ||
11/22/2024 | 3.25 | 3.35 | 3.13 | 3.23 | ||
| 11/21/2024 | 3.25 | 3.35 | 3.13 | 3.23 | 29,891 | |
| 11/20/2024 | 3.01 | 3.49 | 3.01 | 3.28 | 61,082 | |
| 11/19/2024 | 3.10 | 3.25 | 3.01 | 3.15 | 17,840 | |
| 11/18/2024 | 3.10 | 3.16 | 3.01 | 3.16 | 18,958 | |
| 11/15/2024 | 3.46 | 3.46 | 3.04 | 3.11 | 28,616 | |
| 11/14/2024 | 3.09 | 3.33 | 2.99 | 3.31 | 23,963 | |
| 11/13/2024 | 3.11 | 3.34 | 3.03 | 3.05 | 29,609 | |
| 11/12/2024 | 3.15 | 3.27 | 3.05 | 3.19 | 24,269 | |
| 11/11/2024 | 3.00 | 3.25 | 2.95 | 3.05 | 45,334 | |
| 11/08/2024 | 3.18 | 3.18 | 2.95 | 2.95 | 6,007 | |
| 11/07/2024 | 3.01 | 3.14 | 3.00 | 3.09 | 12,519 | |
| 11/06/2024 | 2.97 | 3.05 | 2.88 | 3.04 | 21,091 | |
| 11/05/2024 | 3.03 | 3.13 | 2.96 | 3.04 | 20,936 | |
| 11/04/2024 | 3.10 | 3.26 | 3.01 | 3.14 | 11,980 | |
| 11/01/2024 | 3.12 | 3.17 | 3.00 | 3.10 | 33,047 | |
| 10/31/2024 | 3.20 | 3.27 | 3.10 | 3.20 | 34,069 | |
| 10/30/2024 | 3.32 | 3.32 | 3.10 | 3.10 | 44,966 | |
| 10/29/2024 | 3.12 | 3.28 | 3.12 | 3.24 | 23,967 | |
| 10/28/2024 | 3.04 | 3.30 | 2.95 | 3.21 | 142,009 | |
| 10/25/2024 | 3.38 | 3.45 | 3.20 | 3.37 | 27,805 | |
| 10/24/2024 | 3.54 | 3.58 | 3.30 | 3.40 | 118,987 | |
| 10/23/2024 | 3.21 | 3.60 | 3.19 | 3.60 | 192,840 | |
| 10/22/2024 | 3.13 | 3.30 | 3.13 | 3.29 | 20,674 | |
| 10/21/2024 | 3.27 | 3.39 | 3.12 | 3.22 | 21,347 | |
| 10/18/2024 | 3.40 | 3.40 | 3.21 | 3.33 | 30,113 | |
| 10/17/2024 | 3.37 | 3.37 | 3.26 | 3.28 | 11,001 | |
| 10/16/2024 | 3.36 | 3.44 | 3.27 | 3.35 | 39,392 | |
| 10/15/2024 | 3.29 | 3.40 | 3.22 | 3.39 | 6,670 | |
| 10/14/2024 | 3.37 | 3.37 | 3.21 | 3.27 | 18,200 | |
| 10/11/2024 | 3.42 | 3.42 | 3.20 | 3.34 | 15,701 | |
| 10/10/2024 | 3.28 | 3.50 | 3.22 | 3.41 | 53,438 | |
| 10/09/2024 | 3.02 | 3.37 | 3.02 | 3.31 | 34,884 | |
| 10/08/2024 | 3.05 | 3.15 | 3.02 | 3.02 | 9,244 | |
| 10/07/2024 | 3.11 | 3.14 | 3.03 | 3.11 | 12,261 | |
| 10/04/2024 | 3.01 | 3.12 | 3.01 | 3.11 | 23,371 | |
| 10/03/2024 | 3.06 | 3.07 | 3.00 | 3.00 | 9,327 | |
| 10/02/2024 | 3.01 | 3.05 | 3.00 | 3.05 | 3,600 | |
| 10/01/2024 | 3.01 | 3.06 | 2.77 | 3.01 | 36,300 | |
| 09/30/2024 | 3.16 | 3.16 | 2.95 | 3.00 | 14,300 | |
| 09/27/2024 | 3.16 | 3.20 | 3.03 | 3.12 | 76,000 | |
| 09/26/2024 | 3.16 | 3.17 | 2.91 | 3.07 | 105,000 | |
| 09/25/2024 | 2.61 | 3.10 | 2.59 | 3.06 | 161,300 | |
| 09/24/2024 | 2.59 | 2.70 | 2.56 | 2.56 | 40,400 | |
| 09/23/2024 | 2.68 | 2.69 | 2.60 | 2.60 | 33,300 | |
| 09/20/2024 | 2.79 | 2.80 | 2.65 | 2.68 | 41,000 | |
| 09/19/2024 | 2.78 | 2.91 | 2.78 | 2.78 | 55,200 | |
| 09/18/2024 | 2.73 | 2.83 | 2.70 | 2.72 | 32,500 | |
| 09/17/2024 | 2.65 | 2.77 | 2.60 | 2.73 | 33,000 | |
| 09/16/2024 | 2.38 | 2.63 | 2.31 | 2.58 | 68,500 | |
| 09/13/2024 | 2.18 | 2.32 | 2.15 | 2.29 | 17,300 | |
| 09/12/2024 | 2.32 | 2.32 | 2.13 | 2.13 | 20,300 | |
| 09/11/2024 | 2.38 | 2.38 | 2.30 | 2.32 | 8,600 | |
| 09/10/2024 | 2.44 | 2.44 | 2.36 | 2.38 | 12,900 | |
| 09/09/2024 | 2.41 | 2.50 | 2.40 | 2.45 | 23,400 | |
| 09/06/2024 | 2.41 | 2.53 | 2.40 | 2.41 | 12,200 | |
| 09/05/2024 | 2.45 | 2.50 | 2.41 | 2.45 | 31,900 | |
| 09/04/2024 | 2.51 | 2.55 | 2.48 | 2.50 | 13,200 | |
| 09/03/2024 | 2.61 | 2.68 | 2.50 | 2.56 | 19,400 | |
| 08/30/2024 | 2.62 | 2.71 | 2.60 | 2.62 | 10,300 | |
| 08/29/2024 | 2.54 | 2.68 | 2.54 | 2.64 | 14,300 |
About Grace Therapeutics, Stock history
Grace Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Grace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Grace Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Grace Therapeutics, stock prices may prove useful in developing a viable investing in Grace Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9.4 M | 7.9 M |
Grace Therapeutics, Quarterly Net Working Capital |
|
Grace Therapeutics, Stock Technical Analysis
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Grace Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Grace Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Grace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Grace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0929 | |||
| Jensen Alpha | 0.5339 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.1204 | |||
| Treynor Ratio | (1.75) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |